Abstract
Physiologically based toxicokinetic (PBTK) modeling has been well established to study the distributions of chemicals in target tissues. In addition, the hierarchical Bayesian statistical approach using Markov Chain Monte Carlo (MCMC) simulations has been applied successfully for parameter estimation. The aim was to estimate the constant inhalation exposure concentration (assumed) using a PBTK model based on repeated measurements in venous blood, so that exposures could be estimated. By treating the constant exterior exposure as an unknown parameter of a four-compartment PBTK model, we applied MCMC simulations to estimate the exposure based on a hierarchical Bayesian approach. The dataset on 16 volunteers exposed to 100 ppm (≅0.538 mg/L) trichloroethylene vapors for 4 h was reanalyzed as an illustration. Cases of time-dependent exposures with a constant mean were also studied via 100 simulated datasets. The posterior geometric mean of 0.571, with narrow 95% posterior confidence interval (CI) (0.506, 0.645), estimated the true trichloroethylene inhalation concentration (0.538 mg/L) with very high precision. Also, the proposed method estimated the overall constant mean of the simulated time-dependent exposure scenarios well with slightly wider 95% CIs. The proposed method justifies the accuracy of exposure estimation from biomonitoring data using PBTK model and MCMC simulations from a real dataset and simulation studies numerically, which provides a starting point for future applications in occupational exposure assessment.
Similar content being viewed by others
References
Allen BC, Hack CE, Clewell HJ (2007) Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age. Risk Anal 27(4):947–959
Andersen ME (2003) Toxicokinetic modeling and its applications in chemical risk assessment. Toxicol Lett 138:9–27
Andersen ME, Clewell ML, Gargas FA, Smith FA, Reitz RH (1987) Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol Appl Pharmacol 87:185–205
Andersen ME, Krewski D, Withey JR (1993) Physiological pharmacokinetics and cancer risk assessment. Cancer Lett 69:1–14
Bailer AJ, Dankovic DA (1997) An introduction to the use of physiologically based pharmacokinetic models in risk assessment. Stat Methods Med Res 6:341–358
Bernillon P, Bois FY (2000) Statistical issues in toxicokinetic modeling: a Bayesian Perspective. Environ Health Perspect 108(Suppl 5):883–893
Bois FY (2000) Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ Health Perspect 108(Suppl 2):275–282
Bois FY (2001) Applications of population approaches in toxicology. Toxicol Lett 120:385–394
Bois FY, Jackson ET, Pekari K, Smith MT (1996) Population toxicokinetics of benzene. Environ Health Perspect 104(Suppl 6):1405–1411
Bois FY, Smith TJ, Gelman A, Chang HY, Smith AE (1999) Optimal design for a study of butadiene toxicokinetics in humans. Toxicol Sci 49:213–224
Brown RP, Delp MD, Linstedt SL, Rhomberg LR, Beliles RP (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13(4):407–484
Chen CC, Wu KY, Chang MJW (2004) A statistical assessment on the stochastic relationship between biomarker concentrations and environmental exposures. Stoch Environ Res Risk Assess 18(6):377–385
Clewell HJIII, Gentry PR, Covington TR, Gearhart JM (2000) Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305
Clewell HJ, Tan YM, Campbell JL, Andersen ME (2008) Quantitative interpretation of human biomonitoring data. Toxicol Appl Pharm 231:122–133
Fisher JW (2000) Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. Environ Health Perspect 108(Suppl 2):265–273
Fisher JW, Mahle D, Abbas R (1998) A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol Appl Pharm 152:339–359
Gelman A (1996) Inference and monitoring convergence. In: Gilks WR, Richardson S, Spiegelhalter DJ (eds) Markov Chain Monte Carlo in Practice. Chapman & Hall/CRC, Boca Raton, pp 131–143
Gelman A, Bois FY, Jiang J (1996) Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J Am Stat Assoc 91(436):1400–1412
Georgopoulos PG, Sasso AF, Isukapalli SS, Lioy PJ, Vallero DA, Okino M, Reiter L (2009) Reconstructing population exposures to environmental chemicals from biomarkers: challenge and opportunities. J Expos Sci Environ Epidemiol 19(20):149–171
Gilks WR (1996) Full conditional distributions. In: Gilks WR, Richardson S, Spiegelhalter DJ (eds) Markov Chain Monte Carlo in Practice. Chapman & Hall/CRC, Boca Raton, pp 75–88
Gosselin NH, Brunet RC, Carrier G, Bouchard M, Feeley M (2006) Reconstruction of methylmercury intakes in indigenous populations from biomarker data. J Expos Sci Environ Epidemiol 16:19–29
Karmaus W, Fussman C, Muttineni J, Zhu X (2004) Backward estimation of exposure to organochlorines using repeated measurements. Environ Health Perspect 112(6):710–716
Leung HW (1992) Use of physiologically based pharmacokinetic models to establish biological exposure indexes. Am Ind Hyg Assoc J 53:369–374
Loizou G, Spendiff M, Barton HA, Bessems J, Bois FY, d’Yvoire MB et al (2008) Development of good modeling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps. Regul Toxicol Pharmacol 50(3):400–411
Lyons MA, Yang RSH, Mayeno AN, Reisfeld B (2008) Computational toxicology of chloroform: reverse dosimetry using Bayesian inference, Markov chain Monte Carlo simulation, and human biomonitoring data. Environ Health Perspect 116(8):1040–1046
Roberts GO (1996) Markov chain concepts related to sampling algorithms. In: Gilks WR, Richardson S, Spiegelhalter DJ (eds) Markov Chain Monte Carlo in Practice. Chapman & Hall/CRC, Boca Raton, pp 45–57
Sohn MD, McKone TE, Blancato JN (2004) Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study. J Expos Anal Environ Epidemiol 14:204–213
Tan YM, Liao KH, Conolly RB, Blount BC, Mason AM, Clewell HJ (2006) Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. J Toxicol Environ Health A 69:1727–1756
Tan YM, Liao KH, Clewell HJ (2007) Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling. J Expos Sci Environ Epidemiol 17:591–603
Yokley KA, Evans MV (2007) An example of model structure differences using sensitivity analyses in physiologically based pharmacokinetic models of trichloroethylene in humans. Bull Math Biol 69:2591–2625
Yokley K, Tran HT, Pekari K, Rappaport S, Riihimaki V, Rothman N, Waidyanatha S, Schlosser PM (2006) Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach. Risk Anal 26(4):925–943
Zanini A, Kitanidis PK (2009) Geostatistical inversing for large-contrast transmissivity fields. Stoch Environ Res Risk Assess 23:565–577
Acknowledgments
The authors are most grateful to Dr. F.Y. Bois and Prof. R.S.H. Yang for giving invaluable comments on an earlier manuscript, and Dr. Bois for providing the human trichloroethylene (TCE) dataset (through personal communication). This work was supported by grants from the National Science Council (NSC 96-2118-M-400-001) and the National Health Research Institutes of Taiwan (BS-096-PP-11). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Health Research Institutes of Taiwan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, CC., Shih, MC. & Wu, KY. Exposure estimation using repeated blood concentration measurements. Stoch Environ Res Risk Assess 24, 445–454 (2010). https://doi.org/10.1007/s00477-009-0332-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00477-009-0332-0